Skip to main content
. 2022 Dec 6;12(12):1136. doi: 10.3390/bios12121136

Table 7.

Summary of the non-enzymatic glucose biosensors based on metal-based nanomaterials, metal oxide-based nanomaterials and nanohybrid/nanocomposite.

Electrode
Modification
Nanomaterials Modified Electrode Applied Potential Linearity
(mM)
Sensitivity
(µA mM−1 cm−2)
LOD (µM) Sample Reference
Nanoporous Pt/GCE Alloying–dealloying via electrochemical
deposition
0.45 V 0.0001–8.14 - 7.75 Human blood serum [208]
Nanoporous Pt Alloying–dealloying via electrochemical
deposition
0.40 V 1–13 - - Human blood serum [203]
Nanoporous Au/Au Alloying–dealloying via electrochemical
deposition
0.10 V 0.002–8.11 4374.6 0.36 Human blood serum [204]
AuNPs/PANI/Carbon cloth Electropolymerization - 0.01–10 150.0 3.08 - [209]
AuNP/GCE Seed-mediated growth - 0.1–25 87.5 50 - [205]
AuNPs/ITO Electrodeposition 0.10 V 0.002–8.11 4374.6 0.36 Human blood serum [210]
Concave Pt-Pd/Au Drop-casted Pt-Pd ink −0.05 V 2.4–10.6 11.06 0.15 Serum
R: 98.8–99.85%
[34]
Core-shell Pt-Pd/Au Drop-casted Pt-Pd ink −0.05 V 2.4–9.4 9.939 0.14 -
Core-shell Pt-Pd-Pt Island/Au Drop-casted Pt-Pd ink −0.05 V 1.8–9.4 9.715 0.14 -
Stellated Pt-Pd/Au Drop-casting Pt-pd ink in isopropanol and Nafion −0.05 V 1.8−6 11.62 0.17 -
CuNP-Polyaniline/GCE Electropolymerization 0.20 V 0.4−4 0.474 - - [212]
Cu microspheroids/Carbon-Nomex Electroplating 0.50 V 0.001−3.3 250 1.75 - [213]
CuO urchin/Carbon-Nomex Electroplating 0.50 V 0.001−3.3 320 7.56 -
Nanoporous Cu/SPCE Colloidal crystal templating technique 0.60 V 0.2–1
4–100
3411 0.1 - [214]
Ni nanostructure/
AuNPs/FTO
Physical vapour deposition; electrodeposition 0.65 V 0.005–3.5
3.5–7
893 0.7 Human blood serum [206]
Nafion/Pd@PtOctahedral/CE
(76.2 nm)
Seed-mediated growth −0.05 V 0.25–6
6–20
0.25–5
74.71
28.1
53.14
20.4 - [219]
Nafion/Pd@PtNanocubic/CE (62.7 nm) Seed-mediated growth −0.05 V 5–20
0.25–5
22.9
44.3
24.1 -
Nafion/Pd@PtRhobohe-
dral/CE
(79.3 nm)
Seed-mediated growth −0.05 V 5–20 20.1 33.5 -
1D IONRs-Array/foil Electrochemical anodization +0.6 V 0.005–0.77
0.76–3.67
406.9
134.1
0.1 Human blood serum [222]
IO-ZNRs/FET Hydrothermal growth - 0.05–22 105.75 12 Mouse Blood Serum [221]
IONTs-Array/FTO Hydrothermal growth +0.6 V 0.0001–0.125
0.125–1
1–5
673.3
71.2
9.58
0.1 - [220]
IONWs-MGCE Drop-casting +0.52 V 0.015–8 726.9 6 Human blood serum [225]
PPy-Chitosan-IONPs/ITO Electrochemical deposition +0.18 V 1–16 12 234 [186]
IONPs/Graphene-Chitosan/Pt Immersion +0.5 V 0–26 5.658 16 - [192]
CO defected-CO3O4/GCE Drop-casting 0.55 V 0.2 µM–0.5 mM 2595.7 0.16 Glucose drink [207]
SnOx-CuO Nanorod/GCE Drop-casting and Nafion mix 0.60 V 0.001–6 2303 3.08 Saliva [223]
Pt-gC3N4/ZnO/Au Simple pyrolysis and chemical reduction 0.20 V 0.25–110 mM 3.34 0.1 Human blood serum and urine [202]
N2-doped carbon aerogel (NCA) embedded with CoNx/GCE Drop-casting and Nafion mix 0.30 0.5 μM to 6 mM - 0.1 Saliva and human serum [226]
Ni-Cu LDH@Cu(OH)2 NWs/CuF electrode Device 0.5 0.006–1.6 7.08 1.3 - [227]
Pd nanowire- 3D-PANI/GCE Electrodeposition of PdNW 0.05 0.005–9.8 146.6 0.7 Serum sample
RE: 98.1 to 102.6%
[228]
Pt Nanoporous/
SPCE
Drop-cast 0.4 0–29.97 - - Human whole blood [125]
CS-PPy/TiO2/FTO Electrodeposition 0.13 1–11 302.0 6.7 - [229]
PPy/GOx/DGNs/
Graphite
Electrodeposition/polymerization enzymatic 0.30 V 19.9 59.4 0.07 Human serum, saliva, wine, milk, juice [230]

Abbreviation: CE, carbon electrode; 1D IONRs, one-dimensional iron oxide nanorods; FET, field effect transisitor; IONTs, iron oxide nanotube; Pt-gC3N4, platinum doped carbon nitride; CoNx, DGNs, LDH, layered double hydroxide; FTO, fluorine doped tin oxide; DGNs, dendritic gold nanostructures; Nomex sheet, meta-polyaramid.